*House of Representatives, National Assembly*
*PRESS RELEASE*
For Immediate Release
*House of Representatives Supports Local Production of APIs to Lower Drug Costs*
*Lagos, Nigeria | Monday, July 29, 2024 –* The House Committee on Food and Drugs Administration and Control, chaired by H.E. Rep. Regina Akume, has reaffirmed its commitment to promoting the local production of Active Pharmaceutical Ingredients (APIs) and excipients in Nigeria.
This commitment was disclosed in the course of an ongoing training/workshop organised by the National Agency for Food and Drugs Administration and Control (NAFDAC) under the theme “Unlocking the Healthcare Value Chain.”
Hosted by NAFDAC’s Director-General, Prof. Mojisola Adeyeye, the workshop provided critical insights into API production and regulatory standards. The event was also attended by several distinguished guests and stakeholders, including WHO Representative Dr. Walter Kazadi.
Prof. Adeyeye in her address, highlighted that the training aimed to equip participants with comprehensive knowledge of API regulations, including development, manufacturing, and quality assurance. She underscored the impact of API products on public health and the necessity of local API production to ensure the safety, efficacy, and affordability of pharmaceuticals.
“The training will empower participants to navigate the complexities of API regulations and guidelines effectively. It will also foster the ability to contribute to the development and maintenance of high-quality pharmaceutical products, ensuring public health and safety,” she remarked.
Rep. Akume, represented by the Deputy Chairperson of the Committee, Rep. Uchenna Okonkwo, emphasised the significance of local API production in lowering drug costs and improving access to quality healthcare. She stressed the importance of legislative support in securing adequate funding and developing regulatory frameworks to bolster local manufacturing capabilities.
The Committee Chairperson also assured stakeholders of the 10th House of Representatives’ dedication to enacting laws that will further support local pharmaceutical manufacturing and enhance healthcare delivery in Nigeria. She further reaffirmed her Committee’s commitment to ensuring that NAFDAC receives the necessary resources to strengthen its regulatory role and support the local pharmaceutical sector.
Coordinating Minister of Health and Social Welfare, Prof. Ali Pate, emphasised the benefits of local API production during his remarks at the event. He stated that producing APIs locally will help mitigate foreign exchange challenges and provide drug manufacturers with improved access to raw materials.
Represented by Dr. Abdu Mukhtar, the National Coordinator of the Presidential Unlocking Healthcare Value Chain Initiative, Prof. Pate further highlighted the Federal Ministry of Health’s commitment under his leadership to ensure the production of high-quality API products in Nigeria.
The Ministry will work closely with NAFDAC and other relevant agencies to support this initiative.
“The Ministry of Health has a strategic blue print to encourage local drug manufactures to produce without much challenges,” he added.
World Health Organisation (WHO) Nigeria Country Representative, Dr. Walter Kazadi, stated that WHO’s participation at the Workshop ensures adherence to quality standards and measures before local manufacturers commence production.
Dr. Kazadi noted that Nigeria, like many African countries, relies heavily on importing 90% of pharmaceutical ingredients. However, this training will enable Nigerians to start manufacturing drugs locally.
In alignment with our Legislative Agenda for Healthcare Reform (Agenda 5: Social Sector Reform and Development), the 10th House of Representatives remains committed to advancing initiatives that support the local pharmaceutical industry and ensure access to safe, effective, and affordable medicines for Nigerians.
Signed:
*Rep. Akin Rotimi, Jr.*
House Spokesman
